Physician profile
Sunitha Siram
NPI 1841252418
$4,825.76
in general payments reported to CMS, 2019-2025
40 companies · $721 in 2025
The $721 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $915 · 2020: $161 · 2021: $239 · 2022: $187 · 2023: $1,205 · 2024: $1,396 · 2025: $721.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,322.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $707.91 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Novo Nordisk INC | $695.57 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $653.07 | 2019-2025 | |
| Abbott Laboratories | $490.23 | 2019-2025 | Freestyle Libre 3, Eterna |
| Lilly USA, LLC | $351.58 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Astellas Pharma US INC | $242.06 | 2019-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $207.62 | 2024 | |
| Astrazeneca Pharmaceuticals Lp | $168.89 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $124.74 | 2021-2023 | Vraylar |
| Novartis Pharmaceuticals Corporation | $91.27 | 2019-2025 | |
| Exact Sciences Corporation | $81.79 | 2023-2024 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.93 | 2022-2025 | Ofev |
| Allergan, INC. | $72.97 | 2019-2020 | |
| Amgen INC. | $70.66 | 2019-2025 | Prolia, Evenity, Repatha |
| Optinose US, INC. | $70.09 | 2021-2024 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunitha Siram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.